Tech Talk: Israeli firm wins landmark FDA clearance for injection-based diabetes app

Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes. | Read More in JPost.com – Business & Innovation | The Jerusalem Post.   Read More in Israel NOWlej.